文献速递主动脉外科

胸主动脉疾病意义未明变异与主动脉手术后结局的关联

Association Between Genetic Variants of Uncertain Significance in Thoracic Aortic Disease and Outcomes After Aortic Surgery.
PubMed 文献 · Ann Thorac Surg · 2026-09-10

单中心回顾性研究纳入2012至2023年接受基因检测的胸主动脉瘤或夹层成人患者,比较致病性变异、意义未明变异(VUS)与变异阴性者的术后结局。在713例手术患者中,VUS与死亡或再手术风险增加2倍独立相关(HR 2.13),而致病性变异无显著关联。提示将VUS视为良性可能不足。

要点

  • VUS与主动脉术后死亡或再手术风险增加2倍独立相关。
  • 致病性变异与死亡或再手术无显著关联。
  • A型夹层、B型夹层、降主动脉瘤、弓部动脉瘤及年龄也是显著预测因素。

核心结论

  • 在胸主动脉疾病验证基因中,VUS状态与死亡或再手术风险增加2倍相关,提示当前将其视为良性的管理策略可能不足。

研究设计与样本

  • 单中心回顾性研究,纳入2012至2023年接受基因检测的胸主动脉瘤或夹层成人患者,共1004例,其中713例接受手术。

主要发现

  • 866例(86.3%)为变异阴性,107例(10.7%)为VUS,31例(3.1%)为致病性变异。
  • 中位随访57.4(39.5-82.0)个月,VUS与死亡或再手术风险独立相关(HR 2.13;95% CI 1.35-3.37;P = .001)。
  • 致病性变异与死亡或再手术无显著关联(HR 0.99;95% CI 0.38-2.58;P = .99)。
  • 其他显著预测因素包括A型夹层(HR 3.37)、B型夹层(HR 4.06)、降主动脉瘤(HR 2.04)、弓部动脉瘤(HR 1.92)及手术时年龄较大(HR 1.04)。

临床怎么用

  • 对胸主动脉疾病患者检出VUS时,不应简单视为良性,需加强术后监测与风险分层。

局限性

  • 单中心回顾性设计,需进一步前瞻性研究细化VUS患者的风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic testing increasingly identifies variants of uncertain significance (VUS) in patients with thoracic aortic disease. The impact of VUS on outcomes when they are treated as benign remains unclear. We evaluated the association between genetic variants and surgical outcomes in patients undergoing aortic surgery. METHODS: This single-center retrospective study evaluated adults with thoracic aortic aneurysm or dissection who underwent genetic testing between 2012 and 2023. Patients were classified as having pathogenic variants, VUS, or as variant negative in the 11 primary genes for thoracic aortic disease. The primary outcome was a composite of death or reoperation. Genetic status was assessed with Cox regression analysis with variant negative group as the reference, adjusting for age, sex, bicuspid aortic valve, dissection type, and aneurysm type. RESULTS: Among 1004 patients, 866 (86.3%) were variant negative, 107 (10.7%) had VUS, and 31 (3.1%) had pathogenic variants. Overall, there were 713 patients who underwent surgery, with a median follow-up of 57.4 (39.5-82.0) months. Compared with variant-negative status, the presence of VUS was independently associated with a 2-fold increase in the risk of death or reoperation (hazard ratio [HR], 2.13; 95% CI, 1.35-3.37; P = .001). Pathogenic variants showed no significant association (HR, 0.99; 95% CI, 0.38-2.58; P = .99). Other significant predictors included type A dissection (HR, 3.37), type B dissection (HR, 4.06), descending aneurysm (HR, 2.04), arch aneurysm (HR, 1.92), and greater age at surgery (HR, 1.04). CONCLUSIONS: VUS status in validated thoracic aortic disease genes conferred 2-fold increase in the risk of death or reoperation, suggesting that current management strategies treating these variants as benign may be inadequate. Further prospective studies are needed to refine risk stratification for patients with VUS.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Dankwa S, Phu TA, Erez E, et al. Association Between Genetic Variants of Uncertain Significance in Thoracic Aortic Disease and Outcomes After Aortic Surgery. Ann Thorac Surg. 2026. PMID: 42722264. doi:10.1016/j.athoracsur.2026.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。